Mark N Gillespie

University of Alabama at Birmingham

NIH Rank #8578
  • R01 Holder
  • Translational
  • Early Career

NIH Funding · FY2024

Total Funding
$1.5M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#8,578
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.5M across 3 grants · National rank #8578.

Top grants by award amount

Mark N Gillespie's NIH grant portfolio, ranked by award amount.

  • 1R01HL169587-01A1R01
    The mitochondrial genome in lung disease: a signaling hub linking the persistence and severity of inflammation to recovery
    $724.5K
    award amount
  • 5R01HL031197-29R01
    Mitochondrial DNA Injury is a Key Contributor to the Development of Chemical Lung Injury
    $629.2K
    award amount
  • 3R01HL031197-29S1R01
    Mitochondrial DNA Injury is a Key Contributor to the Development of Chemical Lung Injury
    $148.5K
    award amount

Affiliations

Institutions that have administered grants for Mark N Gillespie.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    University of Alabama at Birmingham
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #8578
  5. 2024
    Multi-Institutional Research
    Awards at 2 institutions